Does GILTERITINIB Cause Cardiomyopathy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Cardiomyopathy have been filed in association with GILTERITINIB (Xospata). This represents 0.3% of all adverse event reports for GILTERITINIB.
9
Reports of Cardiomyopathy with GILTERITINIB
0.3%
of all GILTERITINIB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Cardiomyopathy From GILTERITINIB?
Of the 9 reports, 2 (22.2%) resulted in death, 6 (66.7%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Cardiomyopathy Listed in the Official Label?
Yes, Cardiomyopathy is listed as a known adverse reaction in the official FDA drug label for GILTERITINIB.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which GILTERITINIB Alternatives Have Lower Cardiomyopathy Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB